Best Practices in Breast Cancer – October 2016 Vol 7


Letters from Lillie

JONS Celebrates Breast Cancer Awareness Month

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

Dear Navigators, Over the past couple of decades, our country has made impressive progress in raising awareness of breast cancer. From races for the cure to pink gear on NFL [ Read More ]

Interview with the Innovators

Early Recurrence Detection: Analyzing DNA from Circulating Tumor Cells and Circulating Cell-Free DNA

An Interview with Paul W. Dempsey, PhD, and Paul Y. Song, MD, of Cynvenio

Cynvenio is a cancer diagnostics company offering their Liquid­Biopsy technology to provide molecular analysis of cancer biomarkers in blood. The company purports that molecular diagnostic approaches to cancer detection and [ Read More ]

Uncategorized

Endocrine Therapy Options for Women with Breast Cancer

Endocrine therapy is a valuable treatment option for women whose breast tumors express the estrogen receptor (ER).1 In these women, endocrine therapy can block the tumor’s ability to produce estrogen–a [ Read More ]

Survivorship

The Transformation of Breast Cancer Management

Sharon S. Gentry, RN, MSN, CBCN 

If you are a female in the United States, your lifetime risk of being diagnosed with breast cancer is 1 in 8.1 If you are a male, the risk is [ Read More ]

Uncategorized

Studies Show the Breast Cancer Index Can Help Guide Treatment Strategy for Patients with Early-Stage Invasive Breast Cancer

The Breast Cancer Index (BCI) test is a quantitative assay based on the expression of 11 genes that may help patients with estrogen receptor–positive (ER+), early-stage breast cancers, in consultation [ Read More ]

Original Research

State of Personalized Medicine in Breast Cancer

Sarika Jain,1 Sachin G. Pai,2 Cesar A. Santa-Maria,1 William J. Gradishar1
1Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 2Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 

It was estimated that 231,840 new breast cancers would be diagnosed in 2015, with 40,290 breast cancer–related deaths during the same period in the United States alone.1 With improvements in [ Read More ]

Seventh Annual AONN+ Conference Abstracts

AONN+ Announces the Breast Cancer Research Abstracts to be Presented at the Annual Meeting

The Academy of Oncology Nurse & Patient Navigators (AONN+) is holding its annual meeting November 17-20, 2016, in Las Vegas, NV. In this special breast cancer issue of JONS, we [ Read More ]